INHIBRX
Summary
Inhibrx is a clinical-stage biopharmaceutical company focused on developing biologic therapeutics in oncology and orphan diseases.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
Senior Management
Mark P. Lappe
Founder and CEO